Methods For Treating Ras Driven Cancer In A Subject

  • Published: Jul 2, 2009
  • Earliest Priority: Oct 24 2008
  • Family: 3
  • Cited Works: 0
  • Cited by: 3
  • Cites: 9
  • Additional Info: Full text
Abstract

The invention relates to the discovery that the dibenzodiazepinone analogues have growth inhibiting activities on tumorigenic cells that are driven by expression of RAS or mutated RAS. Thus the invention includes methods for inhibiting the activity of RAS using dibenzodiazepinone analogues; methods for inhibiting the growth of a RAS driven cancer cell using dibenzodiazepinone analogues; methods for inhibiting the growth of a RAS driven cancer using dibenzodiazepinone analogues; and methods for treating a subject having a RAS driven cancer using dibenzodiazepinone analogues.


Claims
Download PDF
Document Preview
Document History
  • Publication: Jul 2, 2009
  • Application: Oct 24, 2008
    US US 25810208 A
  • Priority: Oct 24, 2008
    US US 25810208 A
  • Priority: Aug 15, 2008
    US US 19259508 A
  • Priority: Oct 17, 2007
    US US 98068907 P
  • Priority: Aug 17, 2007
    US US 93555207 P

Download Citation


Sign in to the Lens

Feedback